SOTIO Biotech

📍 Prague, Czechia🗓 Founded 2010👥 248 employees💰 Last funded Nov 2019
Biotechnology Research🌐 sotio.com
Website LinkedIn
SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in SOTIO Biotech?
SOTIO Biotech has 1 investors on record on gritt.io and 1 late-stage investors.
When did SOTIO Biotech last raise funding?
The most recent investment in SOTIO Biotech recorded on gritt.io was in November 2019.
When was SOTIO Biotech founded?
SOTIO Biotech was founded in 2010.
What industry is SOTIO Biotech in?
SOTIO Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SOTIO Biotech based?
SOTIO Biotech is headquartered in Prague, Czechia.